A Resource for Healthcare and Social Services Professionals
Attend a free live training event! Browse trainings by topic, month, or event format (virtual or in-person), and then be sure to register online. Please note this list of upcoming trainings is updated regularly. If you do not see a specific training listed below, please check back or email us with any questions. If you want to be notified of newly booked trainings, subscribe to our mailing list.
DEA-eligible
Topic: Special Populations
This training provides foundational knowledge for those working in addiction treatment settings on best practices for creating welcoming spaces in addiction care for transgender & gender diverse (TGD) individuals.
 |
Tuesday, 1/21/2025 1:00 pm – 2:00 pm ET |
 |
This training fulfills the DEA's 8-hour training requirement for prescribers |
 |
Virtual event |
 |
Intended AudienceProviders, nurses, social workers, psychologists, peer supports, other clinical staff, and non-clinicians. |
Topic: Harm Reduction
This training reviews strategies for reducing communicable infectious diseases associated with injection drug use. We will explore testing strategies and linkage to care for those patients with diagnosed blood-borne pathogens; review bleaching/sterilization of injection paraphernalia, serosorting or sequential drug use to prevent infection of uninfected partners; and discuss pharmacological interventions for infection prevention, including nPEP and PrEP.
|
Tuesday, 1/21/2025 3:00 pm – 4:30 pm ET |
|
This training fulfills the DEA's 8-hour training requirement for prescribers |
|
Virtual event |
|
Intended AudienceThe entire multidisciplinary team providing treatment for substance use disorders in an office-based setting as well as anyone in a clinical or non-clinical position that is interested in learning about harm reduction. |
Topic: Stimulants
This training is a guide for addiction care teams caring for people who use stimulants, including cocaine and methamphetamines. The training will review the basic science of addiction related to stimulants and discuss the practical implementation of evidence-based treatment for patients who use stimulants, with a concentration on outpatient treatment settings.
|
Wednesday, 1/22/2025 2:00 pm – 5:00 pm ET |
|
This training fulfills the DEA's 8-hour training requirement for prescribers |
|
Virtual event |
|
Intended AudienceProviders, nurses, social workers, psychologists, peer supports, other clinical staff, and non-clinicians. |
Topic: Harm Reduction
This training reviews strategies for reducing non-communicable infectious diseases in patients that inject drugs. Topics include post-injection techniques, equipment needed for safe injection, and strategies to reduce skin and soft tissue infections (SSTIs). Additional education will be provided on the basics of wound and abscess care to prevent worsening SSTIs.
|
Thursday, 1/30/2025 4:00 pm – 5:30 pm ET |
|
This training fulfills the DEA's 8-hour training requirement for prescribers |
|
Virtual event |
|
Intended AudienceThe entire multidisciplinary team providing treatment for substance use disorders in an office-based setting as well as anyone in a clinical or non-clinical position that is interested in learning about harm reduction. |
Topic: Harm Reduction
This training teaches strategies for identifying patients experiencing a stimulant overdose and caring for patients experiencing acute psychosis secondary to psychostimulant ingestion. We will focus on warning signs of psychostimulant overdose and strategies to mitigate the harm associated with the patient’s psychotic state, including de-escalation techniques in clinical and community settings.
|
Tuesday, 2/4/2025 3:00 pm – 4:30 pm ET |
|
This training fulfills the DEA's 8-hour training requirement for prescribers |
|
Virtual event |
|
Intended AudienceThe entire multidisciplinary team providing treatment for substance use disorders in an office-based setting as well as anyone in a clinical or non-clinical position that is interested in learning about harm reduction. |
Topic: Stimulants
This training provides an introduction to stimulant use disorder, including evidence-informed treatments and interventions.
|
Thursday, 2/6/2025 1:00 pm – 2:00 pm ET |
|
This training fulfills the DEA's 8-hour training requirement for prescribers |
|
Virtual event |
|
Intended AudienceProviders, nurses, social workers, psychologists, peer supports, other clinical staff, and non-clinicians. |
Topic: Buprenorphine
This training presents a range of evidence-based strategies for initiating buprenorphine treatment within ambulatory care practices. Special attention is directed towards effective measures supporting the transition of patients using illicitly manufactured fentanyl onto prescribed buprenorphine.
|
Thursday, 2/20/2025 1:00 pm – 2:00 pm ET |
|
This training fulfills the DEA's 8-hour training requirement for prescribers |
|
Virtual event |
|
Intended AudienceProviders, nurses, social workers, psychologists, peer supports, other clinical staff, and non-clinicians. |
Topic: Alcohol
This training is designed to provide an introductory overview of alcohol use disorders. We will explore the latest epidemiological data, with a focus on the prevalence and trends of alcohol use and alcohol use disorders in the United States. Diagnostic criteria and screening tools to assess for alcohol use disorders will be discussed. Additionally, we will examine evidence-based interventions to treat alcohol use disorders and support individuals in their recovery.
|
Friday, 2/21/2025 10:00 am – 11:00 am ET |
|
This training fulfills the DEA's 8-hour training requirement for prescribers |
|
Virtual event |
|
Intended AudienceProviders, nurses, social workers, psychologists, peer supports, other clinical staff, and non-clinicians. |
Topic: Buprenorphine
This training provides healthcare providers with advanced knowledge and practical skills to deliver high-quality, patient-centered treatment plans for individuals on buprenorphine for opioid use disorder (OUD). Participants will enhance their confidence in buprenorphine initiation through real-world case studies, exploring low-barrier models of care to improve access for individuals with OUD and strategies to reduce the risk of precipitated withdrawal.
|
Thursday, 2/27/2025 9:00 am – 11:00 am ET |
|
This training fulfills the DEA's 8-hour training requirement for prescribers |
|
Virtual event |
|
Intended AudienceMedical providers (physicians, advanced practice providers), nurses, and other clinical team members that support medical management of opioid use disorder. |
Topic: Harm Reduction
This training reviews the impact of alcohol in the U.S., assessing risk-prevention strategies and clinical approaches for reducing alcohol use. We will also define risky alcohol use, binge consumption, and evidence-based treatments and medications for alcohol use disorder.
|
Thursday, 2/27/2025 4:00 pm – 5:30 pm ET |
|
This training fulfills the DEA's 8-hour training requirement for prescribers |
|
Virtual event |
|
Intended AudienceThe entire multidisciplinary team providing treatment for substance use disorders in an office-based setting as well as anyone in a clinical or non-clinical position that is interested in learning about harm reduction. |
Grayken Center for Addiction TTA is a program of Boston Medical Center (BMC), a 514-bed academic medical center located in Boston's historic South End and the largest safety-net hospital in New England.
The content on this site and the content presented by Grayken Center for Addiction TTA is intended solely to inform and educate healthcare and social service professionals, and shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional. The hospital, the program, and the contributors are not acting as health care providers or professional consultants on behalf of any specific patient and disclaim establishing a provider-patient relationship with any specific patient.